Differing manifestations of respiratory syncytial virus-associated severe lower respiratory tract infections in human immunodeficiency virus type 1-infected and uninfected children.
BACKGROUND
Respiratory syncytial virus (RSV) causes increased morbidity and mortality in immunocompromised children. The outcome of RSV-associated lower respiratory tract infections (LRTI) in HIV-infected children, is less well described.


METHODS
Children from a prospective study evaluating the etiology of
South African Institute for Medical Research/University of the Witwatersrand/Medical Research Council Pneumococcal Diseases Research Unit, Johannesburg.
S A
SA
Madhi
M
M
Venter
A
A
Madhi
M K
MK
Petersen
K P
KP
Klugman
D000367:Age Factors; D000911:Antibodies, Monoclonal; D016470:Bacteremia / Q000150:complications; D002675:Child, Preschool; D015331:Cohort Studies; D005260:Female; D005334:Fever; D015658:HIV Infections / Q000150:complications* / Q000453:epidemiology / Q000401:mortality; D015497:HIV-1; D006801:Humans; D016867:Immunocompromised Host; D007223:Infant; D007231:Infant, Newborn; D007958:Leukocyte Count; D008297:Male; D011014:Pneumonia / Q000150:complications; D015995:Prevalence; D011446:Prospective Studies; D018357:Respiratory Syncytial Virus Infections / Q000150:complications* / Q000453:epidemiology / Q000401:mortality; D012141:Respiratory Tract Infections / Q000150:complications* / Q000453:epidemiology / Q000821:virology; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012307:Risk Factors; D012621:Seasons; D013019:South Africa / Q000453:epidemiology
D000911:Antibodies, Monoclonal